Anatara Lifesciences Ltd has released a press release.
Hong Kong Patent Granted for GaRP
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
Story so far
Earlier from Anatara Lifesciences
- Phase II GaRP-IBS Trial Internal Analyses of Data Subsets
- Funding Advance on R&D Refund
- Phase II GaRP-IBS Trial Headline Analysis of Results
- Phase II GaRP-IBS Trial & Anti-Obesity Project Updates
- Appendix 4D & Half Year Report 31 December 2024
Later from Anatara Lifesciences
- Anatara receives $969,455 in R&D Tax Incentive for FY25
- Appendix 4E & Financial Report 30 June 2025
- Pause in Trading
- Response to ASX Price Query
- Trading Halt
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences